[Brucella endocardititis: clinical particularities and therapeutic modalities].
Brucella infective endocarditis is an uncommon, but serious complication of brucellosis. The aortic valve is the most commonly affected cardiac valve. Due to characteristics of the infection, medical therapy alone is not sufficient in treating the disease and best results are obtained with surgery combination. We describe a case of Brucella endocarditis involving the aortic valve suspected in front of the clinical data and the results of serology, confirmed by the culture of the native valves. In association with the medical treatment, management valve replacement lead to a favorable medium-term evolution.
Ben Khalfallah
A
A
Service de cardiologie, hôpital de Menzel-Bourguiba, 7050 Tunisie. benkhalfallah@planet.tn
Ousji
M
M
Annabi
N
N
Ajili
F
F
Tlili
R
R
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001021:Aortic Valve / Q000187:drug effects / Q000382:microbiology*; D001022:Aortic Valve Insufficiency / Q000175:diagnosis / Q000188:drug therapy / Q000601:surgery; D002006:Brucellosis / Q000175:diagnosis* / Q000188:drug therapy / Q000601:surgery; D004318:Doxycycline / Q000627:therapeutic use; D004697:Endocarditis, Bacterial / Q000175:diagnosis* / Q000188:drug therapy / Q000601:surgery; D005500:Follow-Up Studies; D019918:Heart Valve Prosthesis Implantation; D006801:Humans; D008297:Male; D008875:Middle Aged; D012293:Rifampin / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D004318:Doxycycline; D012293:Rifampin